BioProcess International
bioresearchonline.com     Jul 25, 2008          

BioProcess International provides the biotechnology industry with peer-reviewed editorial necessary to successfully drive products through the biopharmaceutical, biovaccine and biodiagnostic development process. BioProcess International covers the development and manufacture of biopharmaceutical applications including: proteins, peptides, hormones, vaccines, oligonucleotides, gene therapies, cell and tissue therapies, and... [read full story]                    


View all news articles about*:
Biopharmaceuticals Medicines Pharmaceuticals Remedies
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

View other selected articles:

                   

New discovery on how rheumatoid arthritis destroys bone

news-medical.net     10 mins ago          

Researchers have discovered key details of how rheumatoid arthritis (RA) destroys bone, according to a study published in the Aug. 22 edition of the Journal of Biological Chemistry. The findings are already guiding attempts to...                    

comments

BioSpecifics Technologies Corp. Announces Private Placement Offering (PR Newswire)

yahoo.com     2 hrs ago   3 related          

BioSpecifics Technologies Corp. , a biopharmaceutical company developing first in class collagenase based products, announced today that it raised an aggregate amount of $1,125,000 through the sale of 50,000 unregistered shares...                    

comments

3SBio Inc. to Hold Annual General Meeting (PR Newswire)

yahoo.com     6 hrs ago   2 related          

3SBio Inc. , a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the 2008 Annual General Meeting of Shareholders of 3SBio...                    

comments

Emisphere Technologies Inc hires Nicholas J. Hart as vice president, strategy and development

m2.com     10 hrs ago   4 related          

Published in M2 EquityBites on Wednesday, 20 August 2008 at 15:35 GMT Emisphere Technologies Inc (Nasdaq:EMIS), a biopharmaceutical company, declared on 19 August that the company has appointed Nicholas J Hart as vice president...                    

comments